MORTALITY FROM THE 1ST GENERATION ANTIHISTAMINE MEDICATIONS. POLICY OF THE REGULATORS. POSITION OF A PEDIATRICIAN

L.S. Namazova-Baranova

MORTALITY FROM THE 1ST GENERATION ANTIHISTAMINE MEDICATIONS. POLICY OF THE REGULATORS. POSITION OF A PEDIATRICIAN

L.S. Namazova-Baranova

Abstract
About the Author
Cited By
Scopus Cited

About the Author

L.S. Namazova-Baranova

Scientific Center of Children's Health, Russian Academy of Medical Sciences, Moscow
Russian Federation

Review

For citations:

Namazova-Baranova L. MORTALITY FROM THE 1ST GENERATION ANTIHISTAMINE MEDICATIONS. POLICY OF THE REGULATORS. POSITION OF A PEDIATRICIAN. Pediatric pharmacology. 2009;6(3):52.

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 1727-5776 (Print)
ISSN 2500-3089 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Pediatric pharmacology

MORTALITY FROM THE 1ST GENERATION ANTIHISTAMINE MEDICATIONS. POLICY OF THE REGULATORS. POSITION OF A PEDIATRICIAN

About the Author

Review

For citations:

Cookies policy